找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Rheumatoid Arthritis; The Treatment Contro David H. Goddard,Robin C. Butler Textbook 1984Latest edition Macmillan Publishers Limited 1984 A

[復制鏈接]
11#
發(fā)表于 2025-3-23 11:04:58 | 只看該作者
The need for disease-modifying drugsre potentially toxic. Studies to date have indicated that only a small percentage of patients starting treatment with disease-modifying drugs may derive long-term benefit. A high percentage of patients drop out because of adverse reactions. When analysed in terms of cost versus benefit these treatments may be neither effective nor efficient.
12#
發(fā)表于 2025-3-23 14:41:38 | 只看該作者
Gold in the treatment of rheumatoid arthritise achieved at a high price in terms of toxicity; even when long-term treatment is attempted, only a minority of patients will remain on treatment after three years. The place of gold salts in the treatment of rheumatoid arthritis needs to be reassessed.
13#
發(fā)表于 2025-3-23 19:17:55 | 只看該作者
The need for disease-modifying drugsThis is because there is difficulty in determining which parameters accurately reflect disease activity and disease progression. The Stanford health assessment questionnaire, together with newer radiological techniques, may provide the means by which these assessments can be made..These treatments a
14#
發(fā)表于 2025-3-23 23:02:23 | 只看該作者
Gold in the treatment of rheumatoid arthritis reduce symptoms and signs of synovitis and improve patient well-being to a greater extent than placebo. This advantage will persist for one year after injections have been stopped, but can no longer be demonstrated after a further year. There is no compelling evidence that treatment for longer than
15#
發(fā)表于 2025-3-24 03:36:49 | 只看該作者
16#
發(fā)表于 2025-3-24 08:08:33 | 只看該作者
17#
發(fā)表于 2025-3-24 12:19:18 | 只看該作者
Immunosuppressive therapy for rheumatoid arthritisophos-phamide and chlorambucil (alkylating agents), azathioprine (purine analogue) and methotrexate (folic acid analogue). A Medline search and review articles were used to identify clinical trials of these drugs in patients with rheumatoid arthritis. A scoring system was used to assess the design a
18#
發(fā)表于 2025-3-24 17:37:55 | 只看該作者
19#
發(fā)表于 2025-3-24 20:13:59 | 只看該作者
Conclusionspants, one and all, prescribe one or more of these agents almost every working day of their lives, yet the use of these drugs remains highly controversial. How they should be used — indeed, whether some of them should be prescribed at all — and what studies we should be planning to answer these ques
20#
發(fā)表于 2025-3-24 23:28:43 | 只看該作者
Macmillan Publishers Limited 1984
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-30 05:09
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
北宁市| 郯城县| 崇明县| 成都市| 浮梁县| 育儿| 婺源县| 安康市| 泗洪县| 阿城市| 十堰市| 抚远县| 瑞昌市| 宜丰县| 绥化市| 富平县| 正安县| 望奎县| 宁安市| 齐河县| 集安市| 板桥市| 临邑县| 广东省| 海宁市| 隆林| 青神县| 晋州市| 都江堰市| 福贡县| 隆尧县| 靖安县| 萝北县| 益阳市| 稷山县| 吉安市| 达州市| 巴林左旗| 南澳县| 灵川县| 尉犁县|